PMC full text:
J Surg Res. Author manuscript; available in PMC 2016 Jun 1.
Published in final edited form as:
Table 3
Median survival based on stage and histologic subtype (N = 1183)
| Median survival estimates with or without cancer-directed surgery | Disease stage* | ||
|---|---|---|---|
|
| |||
| I, (95% CI) | II, (95% CI) | III, (95% CI) | |
| Epithelioid | |||
| (−) Surgery | 8 (6–11) | 11 (7–19) | 10 (7–13) |
| (+) Surgery | 18 (15–25) | 21 (13–24) | 18 (15–20) |
| Sarcomatoid | |||
| (−) Surgery | 3 (2–4) | 4 (1–5) | 3 (2–5) |
| (+) Surgery | 4 (0.001–25) | 4 (2–8) | 5 (2–8) |
| Biphasic | |||
| (−) Surgery | 15 (1–21) | 6 (1–14) | 6 (1–not reached) |
| (+) Surgery | 6 (2–18) | 11 (3–15) | 13 (8–17) |
*Per the American Joint Committee on Cancer's Cancer Staging Manual Sixth Edition [26].